Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus

Leon Chien Wei Lin, Chen Yu Huang, Bing Yu Yao, Jung Chen Lin, Anurodh Agrawal, Abdullah Algaissi, Bihung Peng, Yu Han Liu, Ping Han Huang, Rong Huay Juang, Yuan Chih Chang, Chien-Te Tseng, Hui Wen Chen, Che Ming Jack Hu

Research output: Contribution to journalArticle

Abstract

The continued threat of emerging, highly lethal infectious pathogens such as Middle East respiratory syndrome coronavirus (MERS-CoV) calls for the development of novel vaccine technology that offers safe and effective prophylactic measures. Here, a novel nanoparticle vaccine is developed to deliver subunit viral antigens and STING agonists in a virus-like fashion. STING agonists are first encapsulated into capsid-like hollow polymeric nanoparticles, which show multiple favorable attributes, including a pH-responsive release profile, prominent local immune activation, and reduced systemic reactogenicity. Upon subsequent antigen conjugation, the nanoparticles carry morphological semblance to native virions and facilitate codelivery of antigens and STING agonists to draining lymph nodes and immune cells for immune potentiation. Nanoparticle vaccine effectiveness is supported by the elicitation of potent neutralization antibody and antigen-specific T cell responses in mice immunized with a MERS-CoV nanoparticle vaccine candidate. Using a MERS-CoV-permissive transgenic mouse model, it is shown that mice immunized with this nanoparticle-based MERS-CoV vaccine are protected against a lethal challenge of MERS-CoV without triggering undesirable eosinophilic immunopathology. Together, the biocompatible hollow nanoparticle described herein provides an excellent strategy for delivering both subunit vaccine candidates and novel adjuvants, enabling accelerated development of effective and safe vaccines against emerging viral pathogens.

Original languageEnglish (US)
Article number1807616
JournalAdvanced Functional Materials
DOIs
StatePublished - Jan 1 2019

Fingerprint

Middle East
vaccines
Vaccines
hollow
Nanoparticles
nanoparticles
antigens
Antigens
mice
pathogens
Pathogens
emerging
Subunit Vaccines
T-cells
Viral Antigens
lymphatic system
viruses
drainage
antibodies
conjugation

Keywords

  • cdGMP adjuvant
  • hollow nanoparticle
  • Middle East respiratory syndrome coronavirus
  • STING
  • virus mimicry

ASJC Scopus subject areas

  • Chemistry(all)
  • Materials Science(all)
  • Condensed Matter Physics

Cite this

Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus. / Lin, Leon Chien Wei; Huang, Chen Yu; Yao, Bing Yu; Lin, Jung Chen; Agrawal, Anurodh; Algaissi, Abdullah; Peng, Bihung; Liu, Yu Han; Huang, Ping Han; Juang, Rong Huay; Chang, Yuan Chih; Tseng, Chien-Te; Chen, Hui Wen; Hu, Che Ming Jack.

In: Advanced Functional Materials, 01.01.2019.

Research output: Contribution to journalArticle

Lin, Leon Chien Wei ; Huang, Chen Yu ; Yao, Bing Yu ; Lin, Jung Chen ; Agrawal, Anurodh ; Algaissi, Abdullah ; Peng, Bihung ; Liu, Yu Han ; Huang, Ping Han ; Juang, Rong Huay ; Chang, Yuan Chih ; Tseng, Chien-Te ; Chen, Hui Wen ; Hu, Che Ming Jack. / Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus. In: Advanced Functional Materials. 2019.
@article{a094c0efd5eb421eab1c61204e12f458,
title = "Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus",
abstract = "The continued threat of emerging, highly lethal infectious pathogens such as Middle East respiratory syndrome coronavirus (MERS-CoV) calls for the development of novel vaccine technology that offers safe and effective prophylactic measures. Here, a novel nanoparticle vaccine is developed to deliver subunit viral antigens and STING agonists in a virus-like fashion. STING agonists are first encapsulated into capsid-like hollow polymeric nanoparticles, which show multiple favorable attributes, including a pH-responsive release profile, prominent local immune activation, and reduced systemic reactogenicity. Upon subsequent antigen conjugation, the nanoparticles carry morphological semblance to native virions and facilitate codelivery of antigens and STING agonists to draining lymph nodes and immune cells for immune potentiation. Nanoparticle vaccine effectiveness is supported by the elicitation of potent neutralization antibody and antigen-specific T cell responses in mice immunized with a MERS-CoV nanoparticle vaccine candidate. Using a MERS-CoV-permissive transgenic mouse model, it is shown that mice immunized with this nanoparticle-based MERS-CoV vaccine are protected against a lethal challenge of MERS-CoV without triggering undesirable eosinophilic immunopathology. Together, the biocompatible hollow nanoparticle described herein provides an excellent strategy for delivering both subunit vaccine candidates and novel adjuvants, enabling accelerated development of effective and safe vaccines against emerging viral pathogens.",
keywords = "cdGMP adjuvant, hollow nanoparticle, Middle East respiratory syndrome coronavirus, STING, virus mimicry",
author = "Lin, {Leon Chien Wei} and Huang, {Chen Yu} and Yao, {Bing Yu} and Lin, {Jung Chen} and Anurodh Agrawal and Abdullah Algaissi and Bihung Peng and Liu, {Yu Han} and Huang, {Ping Han} and Juang, {Rong Huay} and Chang, {Yuan Chih} and Chien-Te Tseng and Chen, {Hui Wen} and Hu, {Che Ming Jack}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/adfm.201807616",
language = "English (US)",
journal = "Advanced Functional Materials",
issn = "1616-301X",
publisher = "Wiley-VCH Verlag",

}

TY - JOUR

T1 - Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus

AU - Lin, Leon Chien Wei

AU - Huang, Chen Yu

AU - Yao, Bing Yu

AU - Lin, Jung Chen

AU - Agrawal, Anurodh

AU - Algaissi, Abdullah

AU - Peng, Bihung

AU - Liu, Yu Han

AU - Huang, Ping Han

AU - Juang, Rong Huay

AU - Chang, Yuan Chih

AU - Tseng, Chien-Te

AU - Chen, Hui Wen

AU - Hu, Che Ming Jack

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The continued threat of emerging, highly lethal infectious pathogens such as Middle East respiratory syndrome coronavirus (MERS-CoV) calls for the development of novel vaccine technology that offers safe and effective prophylactic measures. Here, a novel nanoparticle vaccine is developed to deliver subunit viral antigens and STING agonists in a virus-like fashion. STING agonists are first encapsulated into capsid-like hollow polymeric nanoparticles, which show multiple favorable attributes, including a pH-responsive release profile, prominent local immune activation, and reduced systemic reactogenicity. Upon subsequent antigen conjugation, the nanoparticles carry morphological semblance to native virions and facilitate codelivery of antigens and STING agonists to draining lymph nodes and immune cells for immune potentiation. Nanoparticle vaccine effectiveness is supported by the elicitation of potent neutralization antibody and antigen-specific T cell responses in mice immunized with a MERS-CoV nanoparticle vaccine candidate. Using a MERS-CoV-permissive transgenic mouse model, it is shown that mice immunized with this nanoparticle-based MERS-CoV vaccine are protected against a lethal challenge of MERS-CoV without triggering undesirable eosinophilic immunopathology. Together, the biocompatible hollow nanoparticle described herein provides an excellent strategy for delivering both subunit vaccine candidates and novel adjuvants, enabling accelerated development of effective and safe vaccines against emerging viral pathogens.

AB - The continued threat of emerging, highly lethal infectious pathogens such as Middle East respiratory syndrome coronavirus (MERS-CoV) calls for the development of novel vaccine technology that offers safe and effective prophylactic measures. Here, a novel nanoparticle vaccine is developed to deliver subunit viral antigens and STING agonists in a virus-like fashion. STING agonists are first encapsulated into capsid-like hollow polymeric nanoparticles, which show multiple favorable attributes, including a pH-responsive release profile, prominent local immune activation, and reduced systemic reactogenicity. Upon subsequent antigen conjugation, the nanoparticles carry morphological semblance to native virions and facilitate codelivery of antigens and STING agonists to draining lymph nodes and immune cells for immune potentiation. Nanoparticle vaccine effectiveness is supported by the elicitation of potent neutralization antibody and antigen-specific T cell responses in mice immunized with a MERS-CoV nanoparticle vaccine candidate. Using a MERS-CoV-permissive transgenic mouse model, it is shown that mice immunized with this nanoparticle-based MERS-CoV vaccine are protected against a lethal challenge of MERS-CoV without triggering undesirable eosinophilic immunopathology. Together, the biocompatible hollow nanoparticle described herein provides an excellent strategy for delivering both subunit vaccine candidates and novel adjuvants, enabling accelerated development of effective and safe vaccines against emerging viral pathogens.

KW - cdGMP adjuvant

KW - hollow nanoparticle

KW - Middle East respiratory syndrome coronavirus

KW - STING

KW - virus mimicry

UR - http://www.scopus.com/inward/record.url?scp=85064522604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064522604&partnerID=8YFLogxK

U2 - 10.1002/adfm.201807616

DO - 10.1002/adfm.201807616

M3 - Article

JO - Advanced Functional Materials

JF - Advanced Functional Materials

SN - 1616-301X

M1 - 1807616

ER -